Biomea Fusion, Inc.BMEA

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.32
Market cap
$95.7M
P/E
—
Revenue (TTM)
—
Net income
-$32.5M
Dividend yield
—
1-year total return
-35.6%
Net margin
—
Revenue growth
—
Debt / equity
—

What Biomea Fusion, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$5.3M-$41.6M-$81.8M-$117.3M-$138.4M-$61.8M
Free cash flow-$4.5M-$38.6M-$63.4M-$100.0M-$120.3M—

More on BMEA.

Figures from Biomea Fusion, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.